Keith L. Crandell
Independent DirectorMr. Keith L. Crandell, MBA is Co-Founder of Arch Venture Partners, L.P. and also serves as Managing Director. At Arch Venture Partners, L.P., he also served as Partner. He is also an Advisor of Exposition Ventures. Mr. Crandell serves on numerous boards. He is an Independent Director of 908 Devices Inc. since June 2012 and an Independent Director of Twist Bioscience Corporation since October 2013. He is a Director of Oxford NanoImaging Limited since January 20, 2022. He served as Director of Atlas Data Storage, inc. He is also a Director of Arbor Biotechnologies, Inc., Alfalight, Inc., Boreal Genomics Inc., Ciespace, Crystal IS, Inc., Cytrellis Biosystems, Inc., Digital Genomics, Genturi Inc., Lightcast Discovery, MASS, Permeon Biologics, Inc., PixelEXX Systems, Quarry Technologies, Scale Biosciences, UltraDx, Ultivue, Inc. and Vizgen, Inc. He is a Board Observer at Elephas Biosciences Corporation since September 06, 2022, Slingshot Biosciences, Inc., AIRNA and Quantum Circuits. Additionally, Mr. Crandell is Chairman of the Illinois Venture Capital Association, Trustee of The Chicago History Museum and Director of the Clean Energy Trust. He serves on the Entrepreneurship Advisory Board at the Polsky Center for Entrepreneurship and Innovation, the Investment Advisory Board for the Partners Innovation Fund, the investment advisory board for the Mass General Brigham Innovation Fund, the University of Texas, Arlington Development Board and the Chicago Historical Society Board of Trustees. He has also served as the Chairman of the Advisory Board of the Illinois State Treasurer Technology Development Account since 2004. He teaches entrepreneurship at the Booth School of Business at the University of Chicago. Previously, Mr. Crandell was an Independent Director of Quanterix Corporation from June 2007 until June 07, 2023, a Director at DA32 Life Science Tech Acquisition Corp. from July 27, 2021 until 2023, a Director of Nanosys, Inc. from December 2007 until October 2019 and an Independent Director of Adesto Technologies Corporation from February 2007 until December 2019. He was also a Director of the National Venture Capital Association, Apropos Technology, Inc., Celebrate Express Inc., Reef Point Systems, Inc., AccuMedia.com, ALIS Corporation, Univa, LLC, MicroOptical Devices and Engineering Animation. He served as a Member of the Financial Advisory Board at Patriot Capital, L.P. and was an Executive Officer of Hercules LLC. He was also Senior Manager of ARCH Development Partners, L.L.C. Mr. Crandell focuses on chemicals and specialty materials, life science therapeutics, tools, devices and diagnostics, software, electronics and instrumentation, photonics, semiconductors, optics, nanotechnology and telecommunications. He holds a B.S. in Mathematics & Chemistry from St. Lawrence University, an M.S. in Chemistry from the University Of Texas At Arlington and an M.B.A. from The University of Chicago Booth School of Business.
Positions
- Company NameTwist Bioscience CorporationStock CodeTWSTPositionIndependent DirectorColleagues
- EMEmily Marine LeproustCo-Founder, Board Chair & CEO
- PJPatrick John FinnPresident & COO
- ALAdam LaponisChief Financial Officer
- DCDennis ChoChief Legal Officer & Corporate Secretary
- PGPaula GreenSenior Vice President of Human Resources
- RBRobert B. ChessLead Independent Director
- JJJan JohannessenIndependent Director
- MAMelissa A. StarovasnikIndependent Director
